CW October 2004
Volume 13Issue Number 10 October 2004 ISSN 10593802 A New Hormone Blocker to Treat Prostate CancerThe results of phase II clinical trial using Degarelix (Ferring Pharmaceu-ticals), novel gonadotrophin-releasing hormone (GnRH) blocker, have been presented in the 27th Congress of the Societe Internationale d?Urologie, Hawaii on October 5, 2004.
Go to Previous Page Go to Next Page Source & Additional Reading 27th Congress of the Societe Internationale d?Urologie, Hawaii on October 5, 2004 Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW October 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
